Cargando…

Natural infection as a blueprint for rational HIV vaccine design

So far, the development of a human immunodeficiency virus (HIV) vaccine has been unsuccessful. However, recent progress in the field of broadly neutralizing antibodies (bNAbs) has reinvigorated the search for an HIV vaccine. bNAbs develop in a minority of HIV infected individuals and passive transfe...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Haaren, Marlies M., van den Kerkhof, Tom L. G. M., van Gils, Marit J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5287307/ https://www.ncbi.nlm.nih.gov/pubmed/27649455 http://dx.doi.org/10.1080/21645515.2016.1232785

Ejemplares similares

HIV-1 envelope characteristics that coincide with the development of cross-reactive neutralizing activity in HIV-1 infected patients
por: van den Kerkhof, Tom, et al.
Publicado: (2011)

A rational blueprint for the design of chemically-controlled protein switches
por: Shui, Sailan, et al.
Publicado: (2021)

Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference
por: Wahren, Britta, et al.
Publicado: (2010)

Correction: Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference
por: Wahren, Britta, et al.
Publicado: (2010)

Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010
por: Brinckmann, Sarah, et al.
Publicado: (2011)

Lower Broadly Neutralizing Antibody Responses in Female Versus Male HIV-1 Infected Injecting Drug Users
por: EULER, Zelda, et al.
Publicado: (2019)

The outsiders: eight unconventional CEOs and their radically rational blueprint for success
por: Thorndike, William N
Publicado: (2012)

HIV-1 envelope glycoprotein characteristics that correlate with the development of cross-reactive neutralizing activity in HIV-1 infected individuals
por: van den Kerkhof, TL, et al.
Publicado: (2012)

Blueprints for measuring natural behavior
por: Puścian, Alicja, et al.
Publicado: (2022)

HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity
por: van den Kerkhof, Tom L G M, et al.
Publicado: (2013)

Development of a Preventive HIV Vaccine Requires Solving Inverse Problems Which Is Unattainable by Rational Vaccine Design
por: Van Regenmortel, Marc H. V.
Publicado: (2018)

Leveraging a Structural Blueprint to Rationally Engineer the Rieske Oxygenase TsaM
por: Tian, Jiayi, et al.
Publicado: (2023)

HIV-1 escapes from N332-directed antibody neutralization in an elite neutralizer by envelope glycoprotein elongation and introduction of unusual disulfide bonds
por: van den Kerkhof, Tom L. G. M., et al.
Publicado: (2016)

Novel approaches for the rapid development of rationally designed arbovirus vaccines
por: van Bree, Joyce W.M., et al.
Publicado: (2023)

Primary antibody response after influenza virus infection is first dominated by low-mutated HA-stem antibodies followed by higher-mutated HA-head antibodies
por: Aartse, Aafke, et al.
Publicado: (2022)

Blueprints for Biosensors: Design, Limitations, and Applications
por: Carpenter, Alexander C., et al.
Publicado: (2018)

Why Does the Molecular Structure of Broadly Neutralizing Monoclonal Antibodies Isolated from Individuals Infected with HIV-1 not Inform the Rational Design of an HIV-1 Vaccine?
por: Van Regenmortel, Marc H V
Publicado: (2015)

The rational design of vaccines
por: Bramwell, Vincent W., et al.
Publicado: (2005)

HIV-1 immunogens and strategies to drive antibody responses towards neutralization breadth
por: van Schooten, Jelle, et al.
Publicado: (2018)

The Blueprint
por: Conant, Douglas
Publicado: (2020)

Development of a Blueprint for Integrated Care for Vulnerable Pregnant Women
por: Harmsen van der Vliet-Torij, H. W., et al.
Publicado: (2022)

Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions
por: Schriek, Angela I., et al.
Publicado: (2022)

Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions
por: Schriek, Angela I., et al.
Publicado: (2022)

Developmental Pathways Are Blueprints for Designing Successful Crops
por: Trevaskis, Ben
Publicado: (2018)

Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates
por: van Schooten, Jelle, et al.
Publicado: (2021)

On the irrationality of rational design of an HIV vaccine in light of protein intrinsic disorder
por: Uversky, Vladimir N.
Publicado: (2021)

Optimizing rational vaccine design
por: Guzman, Carlos A.
Publicado: (2009)

Kivy blueprints
por: Vasilkov, Mark
Publicado: (2015)

Elasticsearch blueprints
por: Mohan, Vineeth
Publicado: (2015)

The cosmic blueprint
por: Davies, Paul Charles William
Publicado: (1987)

The cosmic blueprint
por: Davies, Paul Charles William
Publicado: (1987)

Tableau Blueprints
por: Jackson, Ann, et al.
Publicado: (2021)

Implementing analytics: a blueprint for design, development, and adoption
por: Sheikh, Nauman
Publicado: (2013)

The Design Blueprint for a Large-Scale Telehealth Platform
por: Poonsuph, Rattakorn
Publicado: (2022)

Educator's blueprint: A how‐to guide for survey design
por: Hill, Jeffery, et al.
Publicado: (2022)

Genome-Wide Association Study on the Development of Cross-Reactive Neutralizing Antibodies in HIV-1 Infected Individuals
por: Euler, Zelda, et al.
Publicado: (2013)

Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011
por: Ruffin, Nicolas, et al.
Publicado: (2012)

Rational Vaccine Design in the Time of COVID-19
por: Burton, Dennis R., et al.
Publicado: (2020)

The In Vivo Transcriptomic Blueprint of Mycobacterium tuberculosis in the Lung
por: Coppola, Mariateresa, et al.
Publicado: (2021)

Go programming blueprints
por: Ryer, Mat
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hp6p2qc0ivn2ki2m62pbt0o6d7